MACROGENICS INC — Director's Dealing 2024

Mar 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-03-06

Reporting Person: Peters Jeffrey Stuart (Senior VP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-06	Common Stock	M	10875	$11.50	Acquired	19770	Direct
2024-03-06	Common Stock	M	8750	$10.15	Acquired	28520	Direct
2024-03-06	Common Stock	S	19625	$21.50	Disposed	8895	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-06	Employee stock option (right to buy)	$11.50	M	10875	Disposed	2030-02-20	Common Stock (10875)	Direct
2024-03-06	Employee stock option (right to buy)	$10.15	M	8750	Disposed	2032-02-22	Common Stock (8750)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.